NOT FOR REPRINT
Page Printed from: propertycasualty360.com/author/profile/simeon-bennett
Sign In To follow
Johnson & Johnson started a trial of its experimental Ebola vaccine in the U.K. and said it will produce 2 million courses of the shot this year.